Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer PatientsAmy Thomas, Elizabeth M. Jaffee|The Journal of Experimental Medicine|2004Cited by 349